How many patents does
Cayman Chemical Company have?
patents
350
families
25
granted
64
applications
286
US
64
WO
40
EP
36
JP
23
CN
17
KR
16
RoW
154
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Cayman Chemical Company
Top ten assignees appearing on patents
2009 - 2018
| cayman chemical company | 250 |
| myometrics | 51 |
| astrazeneca | 25 |
| merz north america | 19 |
| lasya | 9 |
| corgenix medical corporation | 5 |
| entasis therapeutics | 5 |
| astrazeneca uk | 1 |
| caymam chemical company | 1 |
2009
| cayman chemical company | 19 |
2018
| cayman chemical company | 25 |
| myometrics | 2 |
Cayman Chemical Company
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| difluorolactam compositions for ep4-mediated osteo related diseases and conditions | 58 | 2012 |
| methods of synthesizing a prostacyclin analog | 34 | 2012 |
| multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostagland… 🛈 | 34 | 2008 |
| fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections | 33 | 2008 |
| lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-medi… 🛈 | 27 | 2013 |
| chiral compounds, compositions, products and methods employing same | 17 | 2012 |
| skin lightening compositions | 15 | 2012 |
| methods for manufacturing tetranor-prostaglandin d, j, e, a and f metabolites | 15 | 2010 |
| methods of synthesizing a difluorolactam analog | 14 | 2013 |
| process for the preparation of f-series prostaglandins | 14 | 2009 |